Innate Pharma announces its participation in the H.C. Wainwright 26th Annual Global Investment Conference

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that Arvind Sood, EVP, President of US Operations, is to participate in the upcoming investor conference, detailed below.

• H.C. Wainwright 26th Annual Global Investment Conference
  Date: September 10, 2024 | New York, United States